Cutting-edge science and the future of tuberculosis control

Bulletin of the World Health Organization

Volumn 85, Issue 5, 2007, Pages 410-412

  Broscha, Roland ^a   Vincent, Véronique ^b  

^a INSTITUT PASTEUR   (France)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; ISONIAZID; MOXIFLOXACIN; NITROIMIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

BACTERIUM; DISEASE CONTROL; DNA; DRUG RESISTANCE; GENETIC ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS; PUBLIC HEALTH; TUBERCULOSIS; VACCINATION;

BIOINFORMATICS; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN EXPRESSION; RISK FACTOR; SERODIAGNOSIS; SHORT SURVEY; SPUTUM ANALYSIS; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; BCG VACCINE; CLINICAL LABORATORY TECHNIQUES; DRUG DESIGN; HEALTH PRIORITIES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; RESEARCH SUPPORT; SPUTUM; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH;

EID: 34248157604     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.06.035387     Document Type: Short Survey

References (7)

1. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-44.
2. Perkins MD, O'Brien RJ. New diagnostics for tuberculosis: an essential element for global control and elimination. In: Raviglione MC, ed. Reichman and Hershfield's Tuberculosis: a comprehensive international approach. New York: Informa Healthcare USA; 2006:1115-33.
3. Ginsberg A, Spigelman M. New drugs for tuberculosis. In: Raviglione MC, ed. Reichman and Hershfield's Tuberculosis: a comprehensive international approach. New York: Informa Healthcare USA; 2006:1135-51.
4. Griffin R, Young D. The future of tuberculosis vaccinology. In: Raviglione MC, ed. Reichman and Hershfield's Tuberculosis: a comprehensive international approach. New York: Informa Healthcare USA; 2006:1153-68.
5. Constant P, Perez E, Malaga W, Laneele MA, Saurel O, Daffe M et al. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J Biol Chem 2002;277:38148-58.
6. Sassetti CM, Boyd DH, Rubin EJ. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 2003;48:77-84.
7. Manjunatha UH, Boshoff H, Dowd CS, Zhang L, Albert TJ, Norton JE et al. Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2006;103:431-6.